It binds to G-actin, which speeds up cell migration throughout the entire body
Comparative effectiveness research with established therapies would help determine the relative benefits and risks of these peptides compared to current standard treatments and would inform evidence-based treatment decisions
SS-31 or MOTS-c addresses the mitochondrial dysfunction that underlies metabolic nerve damage
However, GI adverse events may occur in some individuals over a period of 6 months or longer
Hu Y, Li WC, Xu YQ, Li GJ, Liao Y, Fu FL
Its Drug Affinity Complex (DAC) moiety binds to serum albumin, extending its half-life to approximately 68 days and producing sustained, dose-dependent elevations in GH and IGF-1 [1]